The 2017 World Medical Robot Conference was held in Shenzhen. The conference was informed that the domestically assisted abdominal surgery robot is expected to be mass-produced within three years. At this stage, with the gradual recognition of the application of robots in the medical field in China and the popularization of the application of various medical treatment stages, medical robots, especially surgical robots, have become "high-demand products" in the field of robotics, but limited to the requirements of precision in medical applications. The technical threshold for the production of medical robots and the cost of R&D and manufacturing are relatively high. At present, there are already many research teams in China that are working on the development of surgical robots, and have developed a complementary laparoscopic surgical robot system with independent intellectual property rights. Under the influence of comprehensive factors such as favorable policies, increasing aging, increasing consumer groups and accelerating industrialization, China's medical robot market is in a period of rapid growth. Policy promotion, medical robot applications are widely concerned Since 2015, the state has issued a series of important policy documents to promote the transformation and upgrading of China's manufacturing. The medical field as an important livelihood field, and the support for the development and production of medical robots has always been the focus of major policy documents. Whether it is "Made in China 2025", "National Standardization System Construction and Development Plan (2016-2020)", or "Robot Industry Development Plan (2016-2020)", the development of the medical robot industry has been clearly planned and Guide to support and promote the rapid development of the industry. Chart 1: China's medical robot development policy Source: Prospective Industry Research Institute Enterprises involved: domestic and foreign hospitals and enterprises to strengthen the application of research and development At present, almost all mainstream medical robots on the market are produced by foreign companies, and China's medical robot R&D and production enterprises are still affected by factors such as late entry time, lack of technical accumulation and related technical capabilities to support the industry. There is a big gap. Figure 2: Production layout of medical robots in major medical device companies Source: Prospective Industry Research Institute Medical Equipment Disposal,Syringes Needles Sizes,Disposable Syringe,Insulin Syringe FOSHAN PHARMA CO., LTD. , https://www.fospharma.com
